Research ArticleExperimental Studies

Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma

HIROKI NAGARO, HIROSHI ICHIKAWA, KAZUYASU TAKIZAWA, MASAYUKI NAGAHASHI, SHUN ABE, YUKI HIROSE, KAZUKI MORO, KOHEI MIURA, MASATO NAKANO, YOSHIFUMI SHIMADA, JUN SAKATA and TOSHIFUMI WAKAI
Anticancer Research September 2023, 43 (9) 3969-3977; DOI: https://doi.org/10.21873/anticanres.16584

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma
HIROKI NAGARO, HIROSHI ICHIKAWA, KAZUYASU TAKIZAWA, MASAYUKI NAGAHASHI, SHUN ABE, YUKI HIROSE, KAZUKI MORO, KOHEI MIURA, MASATO NAKANO, YOSHIFUMI SHIMADA, JUN SAKATA, TOSHIFUMI WAKAI
Anticancer Research Sep 2023, 43 (9) 3969-3977; DOI: 10.21873/anticanres.16584
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords